Mackenzie Financial
LAB icon

Mackenzie Financial’s Standard BioTools LAB Stock Holding History

Mackenzie Financial’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,781
Closed -$24.7K – 1599
2025
Q4 		$24.7K Hold
19,781
– – ﹤0.01% 1643
2025
Q3 		$25.7K Hold
19,781
– – ﹤0.01% 1679
2025
Q2 		$23.7K Hold
19,781
– – ﹤0.01% 1673
2025
Q1 		$21.4K Hold
19,781
– – ﹤0.01% 1648
2024
Q4 		$34.6K Hold
19,781
– – ﹤0.01% 1671
2024
Q3 		$38.2K Buy
+19,781
New +$38.7K ﹤0.01% 1552

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Mackenzie Financial's LAB Position: Q1 2026 in Review

Mackenzie Financial sold out of Standard BioTools (LAB) in Q1 2026, closing a stake of 19,781 shares — an estimated $24.7K sold.

Mackenzie Financial first reported a position in LAB in Q3 2024 and held it in 6 quarters. The position peaked at $38.2K in Q3 2024. 156 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Mackenzie Financial reported no remaining Standard BioTools position as of Q1 2026 after selling out during the quarter.
  • Mackenzie Financial sold 19,781 Standard BioTools shares in Q1 2026, an estimated $24.7K.
  • Mackenzie Financial first reported a position in Standard BioTools in Q3 2024 and held it in 6 quarters.
  • Mackenzie Financial's Standard BioTools position peaked at $38.2K in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.